Exelixis (EXEL) Other Operating Expenses (2010 - 2026)
Exelixis (EXEL) recorded quarterly Other Operating Expenses of $20.0 million in Q2 2026, down 24.68% quarter-over-quarter from $26.5 million in Q1 2026, and up 4.07% on a YoY basis from $19.2 million in Q2 2025.
Exelixis (EXEL) Other Operating Expenses (2010 - 2026) Analysis & Trends
Exelixis' Other Operating Expenses history runs 16 years deep, the most recent figure standing at $20.0 million for Q2 2026.
- In Q2 2026, Other Operating Expenses rose 4.07% year-over-year to $20.0 million; the TTM figure through Apr 2026 stood at $84.5 million (down 32.81% YoY), while the FY2026 annual figure was $83.7 million, down 34.53% from the prior year.
- Other Operating Expenses was $20.0 million for Q2 2026 at Exelixis, down from $26.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $69.0 million in Q3 2024 to a low of $13.2 million in Q2 2022.
- Historically, Other Operating Expenses has averaged $21.3 million across 5 years, with a median of $18.8 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses plunged 91.16% in 2022, then jumped 267.51% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at $15.9 million in 2022, then surged by 36.64% to $21.8 million in 2023, then soared by 217.18% to $69.0 million in 2024, then tumbled by 73.08% to $18.6 million in 2025, then grew by 7.42% to $20.0 million in 2026.
- The last three Other Operating Expenses figures came in at $20.0 million (Q2 2026), $26.5 million (Q1 2026), and $18.6 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 19.95 Mn |
| Jan 2, 2026 | 26.49 Mn |
| Oct 3, 2025 | 18.57 Mn |
| Jul 4, 2025 | 19.47 Mn |
| Apr 4, 2025 | 19.17 Mn |
| Jan 3, 2025 | 19.92 Mn |
| Sep 27, 2024 | 69.00 Mn |
| Jun 28, 2024 | 17.67 Mn |
| Mar 29, 2024 | 21.26 Mn |
| Dec 29, 2023 | 21.75 Mn |
| Sep 29, 2023 | 18.77 Mn |
| Jun 30, 2023 | 17.71 Mn |
| Mar 31, 2023 | 14.32 Mn |
| Dec 30, 2022 | 15.92 Mn |
| Sep 30, 2022 | 15.31 Mn |
| Jul 1, 2022 | 13.48 Mn |
| Apr 1, 2022 | 13.20 Mn |
| Dec 31, 2021 | 180.19 Mn |
| Oct 1, 2021 | 11.87 Mn |
| Jul 2, 2021 | 14.88 Mn |